Virological response to entecavir reduces the risk of liver disease progression in nucleos(t)ide analogue-experienced HBV-infected patients with prior resistant mutants

Yang Shih-Cheng; Lee Chuan-Mo; Hu Tsung-Hui; Wang Jing-Houng; Lu Sheng-Nan; Hung Chao-Hung; Changchien Chi-Sin; Chen Chien-Hung

首页> 外文期刊>The Journal of Antimicrobial Chemotherapy >Virological response to entecavir reduces the risk of liver disease progression in nucleos(t)ide analogue-experienced HBV-infected patients with prior resistant mutants

【24h】

Virological response to entecavir reduces the risk of liver disease progression in nucleos(t)ide analogue-experienced HBV-infected patients with prior resistant mutants

机译：对恩替卡韦的病毒学应答降低了核苷酸（t）ide类似物经历过乙肝病毒感染并具有先前耐药突变体的患者发生肝病进展的风险

获取原文

获取原文并翻译 | 示例

获取外文期刊封面封底 >>

开具论文收录证明 >>

文献代查 >>

页面导航

摘要
著录项
相似文献
相关主题

摘要

This study investigated the influence of virological response (VR) to entecavir on clinical liver disease progression in nucleos(t)ide analogue (NA)-naive and -experienced patients.

机译：这项研究调查了恩替卡韦的病毒学应答（VR）对未接受过核苷酸（NA）类似物（NA）和有经验的患者临床肝病进展的影响。

著录项

来源
《The Journal of Antimicrobial Chemotherapy》 |2013年第9期|共10页
作者
Yang Shih-Cheng; Lee Chuan-Mo; Hu Tsung-Hui; Wang Jing-Houng; Lu Sheng-Nan; Hung Chao-Hung; Changchien Chi-Sin; Chen Chien-Hung;
展开▼
作者单位

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类治疗学;
关键词
hepatitis B virus; lamivudine; hepatocellular carcinoma;

机译：乙型肝炎病毒拉米夫定肝细胞癌;

相似文献

外文文献
中文文献
专利

1. Virological response to entecavir reduces the risk of liver disease progression in nucleos(t)ide analogue-experienced HBV-infected patients with prior resistant mutants [J] . Yang Shih-Cheng, Lee Chuan-Mo, Hu Tsung-Hui, The Journal of Antimicrobial Chemotherapy . 2013,第9期

机译：对恩替卡韦的病毒学应答降低了核苷酸（t）ide类似物经历过乙肝病毒感染并具有先前耐药突变体的患者发生肝病进展的风险
2. Emergence of entecavir-resistant mutations in nucleos(t)ide-naive Japanese patients infected with hepatitis B virus: virological breakthrough is also dependent on adherence to medication. [J] . Kamezaki H, Kanda T, Wu S, Scandinavian journal of gastroenterology. . 2011,第9期

机译：在感染了乙型肝炎病毒的日本无核核苷酸的日本患者中出现恩替卡韦耐药突变：病毒学突破还取决于对药物的依从性。
3. Liver disease progression and virological response: Entecavir rescue still possible in the setting of rtM204I lamivudineresistant mutation [J] . TanP.S., AungM.O., DanY.Y., Gut: Journal of the British Society of Gastroenterology . 2013,第5期

机译：肝病进展和病毒学应答：在rtM204I拉米夫定耐药突变的情况下仍可进行恩替卡韦抢救
4. Identifying risk of progression for patients with Chronic Kidney Disease using clustering models [C] . Michael Lenart, Nikhil Mascarenhas, Ruisi Xiong, IEEE Systems and Information Engineering Design Symposium . 2016

机译：使用聚类模型确定慢性肾脏病患者的进展风险
5. Patient Experience on Therapy for Hepatitis C Virus, The Impact of Successful Treatment on Liver Stiffness, and The Meaning of Sustained Virologic Response [D] . Nickerson, Jillian Elizabeth 2015

机译：乙型肝炎病毒治疗患者体验，成功治疗对肝硬化的影响，以及持续的病毒性反应的含义
6. Comparison of the Efficacy of Entecavir and Tenofovir in Nucleos(T)ide Analogue-Experienced Chronic Hepatitis B Patients [O] . Eun Ju Cho, Jeong-Hoon Lee, Yuri Cho, -1

机译：恩替卡韦和替诺福韦在类似Nucleos（T）ide的慢性乙型肝炎患者中的疗效比较
7. Virological response to entecavir reduces the risk of liver disease progression in nucleos(t)ide analogue-experienced HBV-infected patients with prior resistant mutants [O] . S.-C. Yang, C.-M. Lee, T.-H. Hu, 2013

机译：对Entecavir的病毒学反应降低了核心（T）IDE模拟的HBV感染患者的肝病进展的风险降低了具有现有抗突变体的患者

Virological response to entecavir reduces the risk of liver disease progression in nucleos(t)ide analogue-experienced HBV-infected patients with prior resistant mutants

摘要

著录项

相似文献

相关主题

期刊订阅